Nothing Special   »   [go: up one dir, main page]

NZ178011A - Aqueous or anhydrous skin per meatiion pharmaceutical composition comprising an aliphatic alcohol having at least il carbon atoms - Google Patents

Aqueous or anhydrous skin per meatiion pharmaceutical composition comprising an aliphatic alcohol having at least il carbon atoms

Info

Publication number
NZ178011A
NZ178011A NZ178011A NZ17801175A NZ178011A NZ 178011 A NZ178011 A NZ 178011A NZ 178011 A NZ178011 A NZ 178011A NZ 17801175 A NZ17801175 A NZ 17801175A NZ 178011 A NZ178011 A NZ 178011A
Authority
NZ
New Zealand
Prior art keywords
meatiion
aqueous
carbon atoms
pharmaceutical composition
aliphatic alcohol
Prior art date
Application number
NZ178011A
Inventor
J Franz
Original Assignee
Sandoz Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ltd filed Critical Sandoz Ltd
Publication of NZ178011A publication Critical patent/NZ178011A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
NZ178011A 1974-07-05 1975-07-03 Aqueous or anhydrous skin per meatiion pharmaceutical composition comprising an aliphatic alcohol having at least il carbon atoms NZ178011A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH931274 1974-07-05

Publications (1)

Publication Number Publication Date
NZ178011A true NZ178011A (en) 1978-07-28

Family

ID=4350618

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ178011A NZ178011A (en) 1974-07-05 1975-07-03 Aqueous or anhydrous skin per meatiion pharmaceutical composition comprising an aliphatic alcohol having at least il carbon atoms

Country Status (14)

Country Link
JP (1) JPS5132724A (en)
AU (1) AU8280175A (en)
BE (1) BE831042A (en)
DE (1) DE2528516A1 (en)
ES (1) ES439113A1 (en)
FR (1) FR2276832A1 (en)
GB (1) GB1518683A (en)
HU (1) HU170215B (en)
IL (1) IL47634A (en)
NL (1) NL7507798A (en)
NZ (1) NZ178011A (en)
SE (1) SE7507414L (en)
YU (1) YU170475A (en)
ZA (1) ZA754304B (en)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS54163810A (en) * 1978-06-14 1979-12-26 Mundipharma Ag Gel composition for local coating
JPS56159310A (en) * 1980-05-14 1981-12-08 Showa Denko Kk Preparation of monofilament having high strength and knot strength
FR2483235A1 (en) * 1980-05-28 1981-12-04 Fabre Sa Pierre TOPICAL COMPOSITIONS CONTAINING RYE AND VINCA ROSEA ERGOT ALKALOIDS FOR THE TREATMENT OF HYPERSEBORRHOES
JPS59216825A (en) * 1983-05-23 1984-12-06 Takeda Chem Ind Ltd External drug for transcutaneous absorption
US4752612A (en) * 1983-07-01 1988-06-21 Nitto Electrical Industrial Co., Ltd. Method and percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US5128376A (en) * 1983-07-01 1992-07-07 Nitto Denko Corporation Method for percutaneously administering physiologically active agents using an adjuvant a solvent and a diol moderator
JPS6013720A (en) * 1983-07-01 1985-01-24 Nitto Electric Ind Co Ltd Percutaneous administration of physiological activator using adjuvant, solvent and diol modulator
US4590190A (en) * 1983-07-01 1986-05-20 Nitto Electric Industrial Co., Ltd. Method for percutaneously administering physiologically active agents using an alcohol adjuvant and a solvent
US4751087A (en) * 1985-04-19 1988-06-14 Riker Laboratories, Inc. Transdermal nitroglycerin delivery system
JPH0735331B2 (en) * 1986-01-16 1995-04-19 久光製薬株式会社 External gel formulation
JPH0735332B2 (en) * 1986-02-25 1995-04-19 久光製薬株式会社 Cream formulation for external use
JPH0759519B2 (en) * 1987-02-23 1995-06-28 株式会社資生堂 Transdermal absorption enhancer and external preparation for skin containing the same
US4746515A (en) * 1987-02-26 1988-05-24 Alza Corporation Skin permeation enhancer compositions using glycerol monolaurate
DE3710216A1 (en) * 1987-03-27 1988-10-06 Rentschler Arzneimittel USE OF DIHYDROERGOTAMINE AND ITS SALTS FOR LOCAL TREATMENT OF TROPHIC DISORDERS
JPH0720866B2 (en) * 1987-05-15 1995-03-08 三生製薬株式会社 Transdermal preparation containing eperisone or tolperisone or their salts
US5223261A (en) * 1988-02-26 1993-06-29 Riker Laboratories, Inc. Transdermal estradiol delivery system
CH679119A5 (en) * 1988-05-13 1991-12-31 Sandoz Ag
GB2230444B (en) * 1989-04-19 1993-12-08 Ritchie Swanson John Therapeutic compositions.
US5219877A (en) * 1989-09-25 1993-06-15 Bristol-Myers Squibb Company Lauryl alcohol as skin penetration enhancer for topical imidazole agents
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
WO1991016929A1 (en) * 1990-05-10 1991-11-14 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
IL98747A0 (en) * 1991-07-05 1992-07-15 Yissum Res Dev Co Ophthalmic compositions
US5681852A (en) * 1993-11-12 1997-10-28 The Procter & Gamble Company Desquamation compositions
ES2171522T3 (en) * 1993-11-12 2002-09-16 Procter & Gamble SCALING COMPOSITIONS CONTAINING SALICILIC ACID AND BIPOLAR COMPOUNDS.
US5821237A (en) * 1995-06-07 1998-10-13 The Procter & Gamble Company Compositions for visually improving skin
US6005135A (en) * 1996-03-21 1999-12-21 Exxon Chemical Patents Inc. Water-borne polymeric vehicle for coating compositions containing an amine or ammonium salt of phenolic ester alcohols
US6096326A (en) * 1997-08-15 2000-08-01 Scandinavian-American Import/Export Corporation Skin care compositions and use
AU775904B2 (en) † 1999-02-08 2004-08-19 Intarcia Therapeutics, Inc. Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
US7258869B1 (en) 1999-02-08 2007-08-21 Alza Corporation Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
US7731947B2 (en) 2003-11-17 2010-06-08 Intarcia Therapeutics, Inc. Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US11246913B2 (en) 2005-02-03 2022-02-15 Intarcia Therapeutics, Inc. Suspension formulation comprising an insulinotropic peptide
WO2006083761A2 (en) 2005-02-03 2006-08-10 Alza Corporation Solvent/polymer solutions as suspension vehicles
DE602007009377D1 (en) 2006-05-30 2010-11-04 Intarcia Therapeutics Inc SECONDARY FLOW MODULATOR WITH AN INTERNAL CHANNEL FOR AN OSMOTIC OUTPUT SYSTEM
MX2009001114A (en) 2006-08-09 2009-02-10 Intarcia Therapeutics Inc Osmotic delivery systems and piston assemblies.
CN105688191A (en) 2007-04-23 2016-06-22 精达制药公司 Suspension formulations of insulinotropic peptides and uses thereof
KR101514342B1 (en) * 2007-11-22 2015-04-22 가부시키가이샤 메드렉스 External preparation composition comprising fatty acid-based inoic liquid as active ingredient
WO2009102467A2 (en) 2008-02-13 2009-08-20 Intarcia Therapeutics, Inc. Devices, formulations, and methods for delivery of multiple beneficial agents
DK2462246T3 (en) 2009-09-28 2017-11-06 Intarcia Therapeutics Inc QUICK ESTABLISHMENT AND / OR END OF SIGNIFICANT STEADY-STATE PHARMACEUTICAL DELIVERY
JP2012020991A (en) 2010-06-16 2012-02-02 Takasago Internatl Corp Transdermal absorption promoter, and external skin formulation thereof
US20120208755A1 (en) 2011-02-16 2012-08-16 Intarcia Therapeutics, Inc. Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
JP5820206B2 (en) 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
JP5820207B2 (en) 2011-09-13 2015-11-24 日東電工株式会社 Transdermal absorption enhancing composition and patch preparation
US9889085B1 (en) 2014-09-30 2018-02-13 Intarcia Therapeutics, Inc. Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
US20170239173A1 (en) 2014-10-30 2017-08-24 Asahi Kasei Kabushiki Kaisha Transdermal absorption enhancer and transdermal absorption enhancement aid
CA2987766A1 (en) 2015-06-03 2016-12-08 Intarcia Therapeutics, Inc. Implant placement and removal systems
SG10201913699QA (en) 2016-05-16 2020-03-30 Intarcia Therapeutics Inc Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en) 2016-06-02 2019-02-05 Intarcia Therapeutics, Inc. Implant placement guide
USD860451S1 (en) 2016-06-02 2019-09-17 Intarcia Therapeutics, Inc. Implant removal tool
JP7286542B2 (en) 2017-01-03 2023-06-05 インターシア セラピューティクス，インコーポレイティド A method comprising continuous administration of a GLP-1 receptor agonist and co-administration of drugs

Also Published As

Publication number Publication date
ES439113A1 (en) 1977-10-16
GB1518683A (en) 1978-07-19
DE2528516A1 (en) 1976-01-22
YU170475A (en) 1984-02-29
AU8280175A (en) 1977-01-13
NL7507798A (en) 1976-01-07
JPS5132724A (en) 1976-03-19
IL47634A (en) 1978-07-31
FR2276832A1 (en) 1976-01-30
IL47634A0 (en) 1975-10-15
HU170215B (en) 1977-04-28
ZA754304B (en) 1977-02-23
FR2276832B1 (en) 1978-10-06
SE7507414L (en) 1976-01-07
BE831042A (en) 1976-01-05

Similar Documents

Publication Publication Date Title
NZ178011A (en) Aqueous or anhydrous skin per meatiion pharmaceutical composition comprising an aliphatic alcohol having at least il carbon atoms
PH13127A (en) Medical sponges
AU507471B2 (en) Skin composition
GB1536283A (en) Alpha-protected oxyimino-beta-oxo-ypsilon-halogeno-butyric acid derivatives
ZA7542B (en) Anhydrous candicidin foam compositions
HU173557B (en) Process for producing 3-amino-indazolecarboxylic acid derivatives and pharmaceutical compositions containing the as active agents
ZA753722B (en) Process for the preparation of analogues of daunomycin
GB1516656A (en) 3-sulphonyloxy-cephem-4-carboxylic acid derivatives
ZA757511B (en) Device for the application of medicaments to the skin of an animal
CA1035228A (en) Catheter unit for cholangiography
MY8200220A (en) Thiazolylazetic acid derivatives
IL48508A (en) Pharmaceutical compositions comprising piperidylindole derivatives
IL45014A0 (en) An isobutyric acid derivative and therapeutic compositions containing it
IL47655A0 (en) Aqueous antiseptic composition
AU507674B2 (en) Compounding pharmaceuticals which are difficult to absorb into bloodstream
GB1539180A (en) 1-cyclopentene-1-propanoic acid derivatives
IL56863A0 (en) 7-cyclopentyl-heptanoic acid derivatives
AU7903975A (en) Indolylacetyl-amino acid derivatives
NZ179201A (en) 2(w-aminoalkyl)isoindol-i-ylcarboxylic acid derivatives
JPS5238034A (en) Medicine containing organosilion compound as active agent
GB2003016A (en) Stabilization of erythrosine in aqueous acidic food systems
PH12304A (en) An aqueous rafoxanide formulations
IL48230A0 (en) Pharmaceutical compositions containing 2-naphthyl-butyric acid derivatives
GB1518199A (en) Prostenoic acid derivatives
MY7800453A (en) 2-chloroethananephosphonic acid derivatives